Clinical Trial Update: Efficacy & Safety Study of Nasalfent (Fentanyl Citrate Nasal Spray) for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids [Phase 3]

View source ↗

Summary

Phase 3 efficacy and safety study of Nasalfent (fentanyl citrate nasal spray) for breakthrough cancer pain in patients taking regular opioids has completed. Thi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer Pain

Drugs mentioned

• Nasalfent (fentanyl)

Snippet

Sponsor: Archimedes Development Ltd | Conditions: Cancer Pain | Phase 3 | Status: COMPLETED